First Report of Clinical Response to Venetoclax in Early T-Cell Precursor Acute Lymphoblastic Leukemia

被引：28
|
作者：
Numan, Yazan [1 ]
Alfayez, Mansour [1 ]
Maiti, Abhishek [1 ]
Alvarado, Yesid [1 ]
Jabbour, Elias J. [1 ]
Ferrajoli, Alessandra [1 ]
Konoplev, Sergej N. [1 ]
Kantarjian, Hagop M. [1 ]
Bose, Prithviraj [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JCO PRECISION ONCOLOGY | 2018年 / 2卷
关键词：
ANTITUMOR-ACTIVITY; BCL-2; INHIBITOR; SENSITIVITY; NAVITOCLAX; ABT-199; PHARMACOKINETICS; SUSCEPTIBILITY; COMBINATION; DEPENDENCE;
D O I：
10.1200/PO.18.00127
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 6
页数：6
相关论文
共 50 条
  • [1] Synergistic Effect of Venetoclax and Bendamustine in Early T-cell Precursor Acute Lymphoblastic Leukemia
    Nguyen, Hong Duc Thi
    Le, Tan Minh
    Lee, Donghyeon
    Cho, Hee Jeong
    Lee, Jungmin
    Sohn, Sang Kyun
    Kim, Jong Gwang
    Ham, Ji Yeon
    Moon, Joon Ho
    Han, Hyung Soo
    Kim, Juhyung
    Baek, Dong Won
    [J]. IN VIVO, 2024, 38 (04): : 1740 - 1749
  • [2] Venetoclax with chemotherapy in relapse/refractory early T-cell precursor acute lymphoblastic leukemia
    Arora, Sankalp
    Vachhani, Pankit
    Bachiashvili, Kimo
    Jamy, Omer
    [J]. LEUKEMIA & LYMPHOMA, 2021, 62 (09) : 2292 - 2294
  • [3] Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review
    Zhao, Yihan
    Jiang, Shiqing
    Tang, Yujun
    Zhao, Lin
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (04) : 483 - 488
  • [4] Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review
    Yihan Zhao
    Shiqing Jiang
    Yujun Tang
    Lin Zhao
    [J]. International Journal of Hematology, 2023, 118 : 483 - 488
  • [5] Venetoclax use in a patient with ataxia telangiectasia and early T-cell precursor acute lymphoblastic leukemia
    Alqahtani, Shaikha
    Ramakrishnan, Ramya
    E, Shuyu
    Wang, Sa A.
    Nunez, Cesar
    McCall, David
    Garcia, Miriam B.
    Roth, Michael E.
    Cuglievan, Branko
    Gibson, Amber
    [J]. PEDIATRIC BLOOD & CANCER, 2024, 71 (08)
  • [6] Relapsed/refractory early T-cell precursor acute lymphoblastic leukemia was salvaged by venetoclax plus HAG regimen
    Xiang Zhang
    Jianhu Li
    Jie Jin
    Wenjuan Yu
    [J]. Annals of Hematology, 2020, 99 : 395 - 397
  • [7] Venetoclax and decitabine in refractory TP53-mutated early T-cell precursor acute lymphoblastic leukemia
    Kong, Jinyu
    Chen, Nan
    Li, Mengyun
    Zhang, Jian
    Wu, Xiaoxia
    Zong, Lihong
    Wu, Depei
    Song, Baoquan
    Qiu, Huiying
    [J]. ANNALS OF HEMATOLOGY, 2022, 101 (03) : 697 - 699
  • [8] Relapsed/refractory early T-cell precursor acute lymphoblastic leukemia was salvaged by venetoclax plus HAG regimen
    Zhang, Xiang
    Li, Jianhu
    Jin, Jie
    Yu, Wenjuan
    [J]. ANNALS OF HEMATOLOGY, 2020, 99 (02) : 395 - 397
  • [9] Venetoclax and decitabine in refractory TP53-mutated early T-cell precursor acute lymphoblastic leukemia
    Jinyu Kong
    Nan Chen
    Mengyun Li
    Jian Zhang
    Xiaoxia Wu
    Lihong Zong
    Depei Wu
    Baoquan Song
    Huiying Qiu
    [J]. Annals of Hematology, 2022, 101 : 697 - 699
  • [10] Short-course Venetoclax With Standard Chemotherapy Is Effective in Early T-cell Precursor Acute Lymphoblastic Leukemia
    Borah, Pronamee
    Dayal, Nitin
    Pathak, Sangeeta
    Naithani, Rahul
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (05) : 271 - 274
12345